Cargando…

SHCBP1 Promotes the Proliferation of Breast Cancer Cells by Inhibiting CXCL2

Breast cancer has the characteristics of high metastasis and recurrence and ranks first in incidence and mortality among female malignant tumors. Shc SH2-domain binding protein 1 (SHCBP1) is an important protein in intracellular signal transduction and cell division, but the role of SHCBP1 in breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xiaoke, Feng, Guang, Nian, Rui, Han, Shuai, Ke, Meiling, Wang, Ling, Li, Wanjun, Tian, Shan, Lu, Hongzhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647193/ https://www.ncbi.nlm.nih.gov/pubmed/38021148 http://dx.doi.org/10.7150/jca.88072

Ejemplares similares

Effects of Resveratrol on Mouse B16 Melanoma Cell Proliferation through the SHCBP1-ERK1/2 Signaling Pathway
por: Yu, Xiaoke, et al.
Publicado: (2023)

Downregulation of SHCBP1 Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells
por: Zhang, Tian, et al.
Publicado: (2021)

SHCBP1 is a novel target and exhibits tumor-promoting effects in gastric cancer
por: Dong, Ya-Dong, et al.
Publicado: (2019)

Retracted: Downregulation of SHCBP1 Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Unexpected Phenotype of Mice Lacking Shcbp1, a Protein Induced during T Cell Proliferation
por: Buckley, Monica W., et al.
Publicado: (2014)

SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFβ Pathway
por: Ren, Chunhong, et al.
Publicado: (2021)

EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation
por: Yin, Hubin, et al.
Publicado: (2022)

EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression
por: Liu, Lei, et al.
Publicado: (2018)

SHCBP1 Promotes Papillary Thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness
por: Geng, Houfa, et al.
Publicado: (2021)

SHCBP1 regulates apoptosis in lung cancer cells through phosphatase and tensin homolog
por: Wang, Fei, et al.
Publicado: (2019)

Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
por: Ding, Jun, et al.
Publicado: (2018)

Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer
por: Shi, Wengui, et al.
Publicado: (2021)

SHCBP1 contributes to the proliferation and self‑renewal of cervical cancer cells and activation of the NF‑κB signaling pathway through EIF5A
por: Deng, Boya, et al.
Publicado: (2023)

Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets
por: Jiang, Fei, et al.
Publicado: (2023)

SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis
por: Peng, Changliang, et al.
Publicado: (2017)

CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE
por: Da, Zhanyun, et al.
Publicado: (2016)

Long Non-Coding RNA TP53TG1 Upregulates SHCBP1 to Promote Retinoblastoma Progression by Sponging miR-33b
por: Wang, Hongyi, et al.
Publicado: (2021)

Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers
por: Wang, Ning, et al.
Publicado: (2022)

PART1 and hsa-miR-429-Mediated SHCBP1 Expression Is an Independent Predictor of Poor Prognosis in Glioma Patients
por: Xuan, Chengmin, et al.
Publicado: (2020)

Monocytes secrete CXCL7 to promote breast cancer progression
por: Wang, Yi-Hsiang, et al.
Publicado: (2021)

HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Chemotaxis and Recruiting of Immune Cells
por: Li, Lili, et al.
Publicado: (2023)

Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells
por: Hu, Shan, et al.
Publicado: (2018)

CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3
por: Campanella, Gabriele S. V., et al.
Publicado: (2010)

Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma
por: Peng, Changliang, et al.
Publicado: (2016)

CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer
por: Guo, Qing, et al.
Publicado: (2015)

Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
por: Lin, Wanjun, et al.
Publicado: (2017)

CXCL13 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells by Inhibiting miR-23a Expression
por: Tian, Feng, et al.
Publicado: (2015)

CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis
por: Uchi, Yusuke, et al.
Publicado: (2016)

CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners
por: Dai, Zhijie, et al.
Publicado: (2021)

MicroRNA-204 Inhibits the Growth and Motility of Colorectal Cancer Cells by Downregulation of CXCL8
por: Shuai, Feng, et al.
Publicado: (2018)

Long non-coding RNA LSINCT5 promotes ovarian cancer cell proliferation, migration and invasion by disrupting the CXCL12/CXCR4 signalling axis
por: Long, Xingtao, et al.
Publicado: (2018)

Effect of CXCL17 on Subcutaneous Preadipocytes Proliferation in Goats
por: Lu, Guangyu, et al.
Publicado: (2023)

miR-223-3p Regulates NLRP3 to Inhibit Proliferation and Promote Apoptosis of ONG Cells
por: Nie, Lili, et al.
Publicado: (2022)

Upregulation of CPE promotes cell proliferation and tumorigenicity in colorectal cancer
por: Liang, Xing-Hua, et al.
Publicado: (2013)

CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis
por: Sun, Yanan, et al.
Publicado: (2014)

PRAF2 is an oncogene acting to promote the proliferation and invasion of breast cancer cells
por: Wang, Yabing, et al.
Publicado: (2022)

Inhibition of lncRNA PCAT19 promotes breast cancer proliferation
por: Feng, Jianyuan, et al.
Publicado: (2023)

CXCL5 secreted from adipose tissue-derived stem cells promotes cancer cell proliferation
por: Zhao, Yuying, et al.
Publicado: (2018)

SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis
por: Liu, Yang, et al.
Publicado: (2020)

Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells
por: Maxwell, Pamela J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kpkiodlhic12gpaoag8gd2ct00